{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:12:41Z","timestamp":1793661161400,"version":"4.5.1"},"reference-count":22,"publisher":"SAGE Publications","issue":"1-2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Allergy, Immunology, and Pulmonology"],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>\n                      <jats:italic toggle=\"yes\">Introduction:<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>Ataxia-telangiectasia (AT) is an autosomal recessive neurodegenerative disease characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia, humoral and cellular immunodeficiency, sensitivity to ionizing radiation, and a tendency to malignancy. The aim of this study was to evaluate the demographic characteristics, immunodeficiency status, laboratory findings, and prognosis of children with AT based on a single-center experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic toggle=\"yes\">Patients and Methods:<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>Nineteen pediatric patients diagnosed with AT between 2003 and 2024 were retrospectively analyzed at a single tertiary center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>The study included 11 male and 8 female patients, with a mean follow-up duration of 72.6 \u00b1 41.3 months. The mean ages at symptom onset and diagnosis were 30.47 \u00b1 23.7 months and 82.32 \u00b1 26.5 months, respectively. The most common presenting symptoms were gait instability, ocular telangiectasia, and recurrent respiratory tract infections. Immunological evaluation revealed IgA deficiency in 57.9% of the patients and IgG deficiency in 15.8%. A hyper-IgM AT phenotype was identified in two patients (10.5%). During follow-up, bronchiectasis and hepatosteatosis developed in 26.3% of the patients. One patient (5.2%) developed type 2 diabetes mellitus, and malignancy occurred in three patients (15.7%). Overall, 6 patients (31.5%) died during the follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>Ataxia-telangiectasia is a rare multisystem disorder associated with significant morbidity and mortality. Early diagnosis, comprehensive multidisciplinary follow-up, regular malignancy surveillance, and preventive strategies for recurrent sinopulmonary infections are essential for improving clinical outcomes and prognosis in affected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/2151321x261463062","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:08:03Z","timestamp":1781716083000},"page":"30-35","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical, Immunological Findings, and Outcomes of Children with Ataxia-Telangiectasia: A Single Center Experience"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3774-3994","authenticated-orcid":false,"given":"Serenay","family":"Cetinoglu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Dr. Beh\u00e7et Uz Child Disease and Pediatric Surgery Hospital, University of Health Sciences, Izmir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selime","family":"Ozen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Dr. Beh\u00e7et Uz Pediatric Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idil Akay","family":"Haci","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Dr. Beh\u00e7et Uz Pediatric Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilke","family":"Taskirdi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Dr. Beh\u00e7et Uz Pediatric Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Akcal","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Istanbul Medipol University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Sirin","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Dr. Beh\u00e7et Uz Pediatric Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Gulez","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Dr. Beh\u00e7et Uz Pediatric Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferah","family":"Genel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Dr. Beh\u00e7et Uz Pediatric Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2024.101169"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264177"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7792600"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1313915"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.01.009"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.12.950"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1526-0542(04)90043-7"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.12.029"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1292131"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.972952"},{"key":"e_1_3_3_12_1","first-page":"1070","article-title":"Pulmonary function in adolescents and young adults with ataxia telangiectasia","volume":"53","author":"McGrath-Morrow SA","year":"2018","unstructured":"11.McGrath-Morrow SA, , Lefton-Greif MA, , Crawford TO, et al. Pulmonary function in adolescents and young adults with ataxia telangiectasia. Pediatr Pulmonol 2018;53:1070\u20131077.","journal-title":"Pediatr Pulmonol"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13037"},{"key":"e_1_3_3_14_1","first-page":"32","article-title":"Health risks for ataxia telangiectasia patients and ATM mutation carriers","volume":"90","author":"van Os NJH","year":"2016","unstructured":"13.van Os NJH, , Roeleveld N, , Weemaes CMR, et al. Health risks for ataxia telangiectasia patients and ATM mutation carriers. Clin Genet 2016;90:32\u201342.","journal-title":"Clin Genet"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423"},{"key":"e_1_3_3_16_1","first-page":"2061","article-title":"Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia","volume":"125","author":"Suarez F","year":"2015","unstructured":"15.Suarez F, , Mahlaoui N, , Canioni D, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia. Blood 2015;125:2061\u20132068.","journal-title":"Blood"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.10.023"},{"issue":"1","key":"e_1_3_3_18_1","first-page":"19","article-title":"Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: A study using nephelometric technique","volume":"48","author":"Aksu G","year":"2006","unstructured":"17.Aksu G, , Genel F, , Koturo\u011flu G, et al. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: A study using nephelometric technique. Turk J Pediatr 2006;48(1):19\u201324.","journal-title":"Turk J Pediatr"},{"issue":"2","key":"e_1_3_3_19_1","first-page":"125","article-title":"Peripheral blood lymphocyte subsets in healthy Turkish children","volume":"46","author":"Ikincio\u011fullari A","year":"2004","unstructured":"18.Ikincio\u011fullari A, , Kendirli T, , Do\u011fu F, et al. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr 2004;46(2):125\u2013130.","journal-title":"Turk J Pediatr"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-017-0011-z"},{"key":"e_1_3_3_21_1","first-page":"83","article-title":"Demographic and systemic manifestations of patients diagnosed with ataxia-telangiectasia","volume":"12","author":"\u00c7atal F","year":"2014","unstructured":"20.\u00c7atal F, , Topal E, , \u00c7eliksoy MH, et al. Demographic and systemic manifestations of patients diagnosed with ataxia-telangiectasia. Ast\u0131m Allerji \u0130mm\u00fcnoloji 2014;12:83\u201390.","journal-title":"Ast\u0131m Allerji \u0130mm\u00fcnoloji"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-024-09494-5"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omaf237"}],"container-title":["Pediatric Allergy, Immunology, and Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2151321X261463062","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2151321X261463062","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2151321X261463062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:11:13Z","timestamp":1787065873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2151321X261463062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,6,1]]}},"alternative-id":["10.1177\/2151321X261463062"],"URL":"https:\/\/doi.org\/10.1177\/2151321x261463062","relation":{},"ISSN":["2151-321X","2151-3228"],"issn-type":[{"value":"2151-321X","type":"print"},{"value":"2151-3228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}